Advertisement
Screener

Inhibikase Therapeutics, Inc. (IKT) ROA

Inhibikase Therapeutics, Inc. (IKT) ROA

  • 2026-06-30: ROA -37.07%.
  • 2026-03-31: ROA -29.40%.
  • 2025-12-31: ROA -26.63%.
  • 2025-09-30: ROA -59.87%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-37.07%
2026-03-31-29.40%
2025-12-31-26.63%
2025-09-30-59.87%
2025-06-30-46.71%
2025-03-31-38.77%
2024-12-31-27.91%
2024-09-30-447.01%
2024-06-30-208.26%
2024-03-31-173.48%
2023-12-31-131.17%
2023-09-30-106.99%
2023-06-30-85.15%
2023-03-31-63.53%
2022-12-31-72.40%
2022-09-30-65.84%
2022-06-30-55.29%
2022-03-31-43.73%
2021-12-31-34.82%
2021-09-30-23.88%
2021-06-30-14.53%
2021-03-31-41.58%
2020-12-31-19.27%

Annual ROA

DateROA
2025-12-31-26.63%
2024-12-31-27.91%
2023-12-31-131.17%
2022-12-31-72.40%
2021-12-31-34.82%
2020-12-31-19.27%

Similar stocks

Stock NameCountryMarket CapPE Ratio
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Liminatus Pharma, Inc. (LIMN)United States$0.282B
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Ocugen, Inc. (OCGN)United States$0.343B-6.34